Issues with care in the elderly patient presenting with acute ischemia
The issues surrounding care of the elderly patient with acute coronary syndromes (ACS) present significant challenges to clinicians and investigators. The elderly often have atypical symptoms of acute ischemia, have greater medical comorbidities, and are more likely to die from ischemic heart disease. Important differences exist among elderly patients with ACS as compared with their younger counterparts, including age-related changes in physiology, metabolism of drugs, and overall functional status, all of which influence treatment patterns and clinical outcomes. Given the absence of elderly patients in many clinical trials, these high-risk individuals are sometimes managed with more conservative strategies, which at times diverge from accepted guidelines. This review addresses clinically important issues in the care of elderly patients with acute ischemia and highlights recent studies that provide new insight into this complex area of cardiovascular care.
Unable to display preview. Download preview PDF.
References and Recommended Reading
- 1.Kochanek KD, Smith BL: Deaths: Preliminary Data for 2002. National Vital Statistics Reports, vol 52, no 13. Hyattsville, MD: National Center for Health Statistics; 2004.Google Scholar
- 5.Brieger D, Eagle KA, Goodman SG, et al.: Acute coronary syndromes without chest pain, an underdiagnosed and undertreated high-risk group: insights from the Global Registry of Acute Coronary Events. Chest 2004, 126:461–469. Report from GRACE of characteristics and outcomes of patients who present with atypical symptoms defined as lack of chest pain. Particularly important for its implications to elderly populations with ischemia.PubMedCrossRefGoogle Scholar
- 19.Braunwald E, Antman EM, Beasley JW, et al.: ACC/AHA guideline update for the management of patients with unstable angina and non-ST segment elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Unstable Angina); 2002. Available at http:// www.acc.org/clinical/guidelines/unstable/unstable.pdfGoogle Scholar
- 22.Walston J, McBurnie MA, Newman A, et al.: Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study. Arch Intern Med 2002, 162:2333–2341. Report of findings in the Cardiovascular Health Study linking syndrome of frailty to inflammatory and coagulation activation.PubMedCrossRefGoogle Scholar
- 33.Ades PA: Introduction-the elderly in cardiac rehabilitation. Am J Geriatr Cardiol 1999, 8:61–62.Google Scholar
- 37.Alter DA, Manuel DG, Gunraj N, et al.: Age, risk-benefit trade-offs, and the projected effects of evidence based therapies. Am J Med 2004, 116:540–545. An assessment of the extrapolation of trial data to populations not studied, specifically the elderly, which emphasized that their increased burden of disease makes the elderly likely to achieve similar or greater benefit from therapy despite lack of representation in trials.PubMedCrossRefGoogle Scholar
- 39.Fibrinolytic Therapy Trialists’ (FTT) Collaborative Group: Indications for brinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994, 343:311–322.Google Scholar
- 44.Cohen M, Demers C, Gurfinkel EP, et al.: A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-QWave Coronary Events Study Group. N Engl J Med 1997, 337:447–452.PubMedCrossRefGoogle Scholar
- 50.Bach RG, Cannon CP, Weintraub WS, et al.: The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndromes. Ann Intern Med 2004, 141:186–195. An analysis of benefit and risk of invasive or conservative management strategy in the elderly (age 65 years) in the TACTICS-TIMI-18 study, which demonstrates routine early invasive therapy improves ischemic outcomes with an associated risk of bleeding.PubMedGoogle Scholar